PhRMA’s Post

View organization page for PhRMA, graphic

56,521 followers

The CBO's report that increasing Hep C treatments would save billions continues to demonstrate the long-term value of medicines. These are the same cures insurers once falsely claimed would bankrupt the system. This data speaks to a bigger story of how payers continue to share a misleading narrative about the cost of new, innovative medicines. Insurers use these scare tactics to restrict & deny coverage to patients. As we've seen with Hep C and other treatments, these claims are false. Read more about the CBO report: https://lnkd.in/ePjf3HiH And more on insurers' misleading narratives here: https://lnkd.in/ex9nWFfS

Boosting hepatitis C treatment would save money, CBO says

Boosting hepatitis C treatment would save money, CBO says

axios.com

To view or add a comment, sign in

Explore topics